Navigation Links
VIASPACE Subsidiary Wins $786,000 U.S. Navy Contract
Date:10/21/2008

PASADENA, Calif., Oct. 21 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) subsidiary Ionfinity has been awarded a $786,000 Phase II contract for its proposal entitled "Miniature Electronic Sniffer for Navy Vertical Take off Unmanned Aerial Vehicles (VTUAVs)" by the Navy's Small Business Technology Transfer (STTR) Program. This competitively selected two year contract will result in a field demonstration of high sensitivity detection and analysis capability for chemical, explosive, and illegal drug residues in the holds and storage bays of suspect vessels. In addition to developing products for the $55 billion security industry, the new sensor technology is expected to have commercial applications in environmental monitoring, agriculture and medicine.

Ionfinity's contract is to develop a sensitive miniaturized sniffer through a joint collaboration with NASA's Jet Propulsion Laboratory, Caltech, General Dynamics, Sionex, and Imaginative Technologies. This chemical sensor system consists of a new and powerful detector called a Differential Mobility Spectrometer, a novel "soft-ionization" method that does not fragment or multiply ionize-sampled specimens, and a micro-gas chromatograph for confirmation and enhanced detection capability all integrated into a compact stand-alone system. The goal of the effort is to demonstrate detection of chemical, explosive, and illegal drug residues in the holds and storage bays of suspect vessels. The device will detect chemicals and materials of interest at ppb levels after 6 seconds. The sensor will be completely self contained with respect to power and communications and only physically attach to the VTUAV for lowering into or on to the vessel of interest.

Ionfinity Chief Operating Officer, and Principal Investigator for this effort, James Weiss, reports, "This new sensor will change the paradigm used for future chemical detection and analysis, making it much more convenient, sensitive, selective and timely."

About VIASPACE: Originally founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA's Jet Propulsion Laboratory. For more information, please visit our website at http://www.VIASPACE.com, or contact for Investor Relations, Dr. Jan Vandersande, Director of Communications at 800-517-8050, or IR@VIASPACE.com.

This news release includes forward-looking statements. These forward-looking statements relate to future events or our future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include the risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-KSB, for the fiscal year ended December 31, 2007, as well as general economic and business conditions, the ability to acquire and develop specific projects and technologies, the ability to fund operations, changes in consumer and business consumption habits, and other factors over which VIASPACE has little or no control.


'/>"/>
SOURCE VIASPACE Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
2. Eagle Ventures Subsidiary Hydrate2O Receives 2008 Top Gear of the Year Award From ShapeYou.com
3. American Media, Inc. Provides Dial-In Information for July 30 Call With Noteholders of American Media Operations, Inc. Subsidiary
4. XL Capital Ltd Issues Statement Regarding Merrill Lynch Lawsuit Against XL Capital Assurance Inc. (XLCA) a Subsidiary of Security Capital Assurance Ltd
5. AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort
6. Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk)
7. Natural Nutrition Subsidiary InterACTIVE Nutrition Reports First Quarter Revenue of $4,189,048 (CDN) and EBITDA of $504,500 (CDN)
8. Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA
9. Natural Nutrition Renames Former Business Lending Subsidiary i-Nutrition, Inc.
10. Barrs PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
11. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: